{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -0.31, "epsForward": -3.56, "sharesOutstanding": 12319500, "bookValue": 0.77, "fiftyDayAverage": 668.15, "fiftyDayAverageChange": -83.150024, "fiftyDayAverageChangePercent": -0.124448135, "twoHundredDayAverage": 652.8625, "twoHundredDayAverageChange": -67.86249, "twoHundredDayAverageChangePercent": -0.10394607, "marketCap": 74491560, "forwardPE": -1.6432586, "priceToBook": 759.7403, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "4basebio UK Societas", "nameChangeDate": "2023-05-11", "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "currency": "GBp", "financialCurrency": "GBP", "regularMarketOpen": 570.0, "averageDailyVolume3Month": 1808, "averageDailyVolume10Day": 1405, "fiftyTwoWeekLowChange": 195.0, "fiftyTwoWeekLowChangePercent": 0.5, "fiftyTwoWeekRange": "390.0 - 750.0", "fiftyTwoWeekHighChange": -165.0, "fiftyTwoWeekHighChangePercent": -0.22, "fiftyTwoWeekLow": 390.0, "fiftyTwoWeekHigh": 750.0, "earningsTimestamp": 1683802740, "earningsTimestampStart": 1683802740, "earningsTimestampEnd": 1683802740, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1613548800000, "priceHint": 2, "marketState": "POSTPOST", "regularMarketChange": -10.0, "regularMarketTime": 1683900579, "regularMarketDayHigh": 584.0, "regularMarketDayRange": "561.0 - 584.0", "regularMarketDayLow": 561.0, "regularMarketVolume": 1031, "regularMarketPreviousClose": 595.0, "bid": 540.0, "ask": 620.0, "fullExchangeName": "LSE", "regularMarketChangePercent": -1.6806724, "regularMarketPrice": 585.0, "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "esgPopulated": false, "exchange": "LSE", "shortName": "4BASEBIO PLC ORD EUR1.00", "longName": "4basebio PLC", "messageBoardId": "finmb_700375712", "market": "gb_market", "symbol": "4BB.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "25 Norman Way", "address2": "Over", "city": "Cambridge", "zip": "CB24 5QE", "country": "United Kingdom", "phone": "44 1223 967 943", "website": "https://www.4basebio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "4basebio PLC engages in the design, development, manufacturing, and supply of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company provides research kits, bulk enzymes, and other products, as well as licensing services; and AVV manufacturing services. It serves biotech, pharma, and contract development and manufacturing organization customers. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was incorporated in 2020 and is based in Cambridge, United Kingdom.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Heikki  Lanckriet Ph.D.", "age": 45, "title": "CEO, Chief Scientific Officer & Exec. Director", "yearBorn": 1977, "fiscalYear": 2021, "totalPay": {"raw": 427600, "fmt": "427.6k", "longFmt": "427,600"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. David  Roth", "title": "CFO, Company Sec. & Exec. Director", "fiscalYear": 2021, "totalPay": {"raw": 308200, "fmt": "308.2k", "longFmt": "308,200"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark  Cooper", "title": "Head of Manufacturing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}